{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:03:42Z","timestamp":1772251422031,"version":"3.50.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00642","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:53:01Z","timestamp":1593651181000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder"],"prefix":"10.3389","volume":"11","author":[{"given":"Attila","family":"Szabo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim A.","family":"Akkouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine Vik","family":"Lagerberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Dieset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bjella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Le Hellard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Kristin","family":"Stavrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Melle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srdjan","family":"Djurovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.200790144","article-title":"History of cannabis and its preparations in saga, science, and sobriquet","volume":"4","author":"Russo","year":"2007","journal-title":"Chem Biodivers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002286","article-title":"The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons","volume":"13","author":"Njoo","year":"2015","journal-title":"PloS Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-017-9806-x","article-title":"Delta-9-Tetrahydrocannabinol (\u03949-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats","volume":"33","author":"Suliman","year":"2018","journal-title":"Neurotox Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex","volume":"56","author":"Sales","year":"2018","journal-title":"Mol Neurobiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1381","article-title":"Positive and Negative Effects of Cannabis and Cannabinoids on Health","volume":"105","author":"Cohen","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrn.2016.28","article-title":"Keep off the grass? Cannabis, cognition and addiction","volume":"17","author":"Curran","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/463009a","article-title":"A decade for psychiatric disorders","volume":"463","year":"2010","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nn.3922","article-title":"Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways","volume":"18","year":"2015","journal-title":"Nat Neurosci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2017.06.005","article-title":"Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses","volume":"65","author":"Aas","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations","volume":"44","author":"M\u00fcller","year":"2018","journal-title":"Schizophr Bull"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01487","article-title":"Targeting Cannabinoid Signaling in the Immune System: \u201cHigh\u201d-ly Exciting Questions, Possibilities, and Challenges","volume":"8","author":"Olah","year":"2017","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/590409","article-title":"Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis","volume":"2014","author":"Wojkowska","year":"2014","journal-title":"Mediators Inflammation"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2015.11.027","article-title":"Cannabis use is associated with 3 years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119)","volume":"170","author":"Helle","year":"2016","journal-title":"Schizophr Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718004142","article-title":"Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors - inflammatory markers and immune activation in severe mental disorders","volume":"49","author":"M\u00f8rch","year":"2019","journal-title":"Psychol Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/schbul\/sbp034","article-title":"Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group","volume":"37","author":"Simonsen","year":"2011","journal-title":"Schizophr Bull"},{"key":"B18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/schbul\/16.1.57","article-title":"Diagnosis of alcohol use disorders in schizophrenia","volume":"16","author":"Drake","year":"1990","journal-title":"Schizophr Bull"},{"key":"B19","article-title":"Clinical rating scales: Alcohol Use Scale (AUS), Drug Use Scale (DUS), and Substance Abuse Treatment Scale (SATS)","volume-title":"Outcomes Assessment in Clinical Practice","author":"Drake","year":"1996"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142489","article-title":"EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research","volume":"70","author":"Beyer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"12654","DOI":"10.1038\/s41598-018-30898-5","article-title":"Expression of TCN1 in Blood is Negatively Associated with Verbal Declarative Memory Performance","volume":"8","author":"Akkouh","year":"2018","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000097202","article-title":"Passage of cytokines across the blood-brain barrier","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2016.03.018","article-title":"The role of interleukin-6 signaling in nervous tissue","volume":"1863","author":"Rothaug","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1146\/annurev.immunol.15.1.797","article-title":"Gp130 and the interleukin-6 family of cytokines","volume":"15","author":"Taga","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh396","article-title":"Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+ CD25- and CD25high regulatory T cells","volume":"18","author":"Oberg","year":"2006","journal-title":"Int Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22739","article-title":"Analysis of IL-6\/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M","volume":"63","author":"Hsu","year":"2015","journal-title":"Glia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1988.tb14384.x","article-title":"Plasma clearance, organ distribution and target cells of interleukin-6\/hepatocyte stimulating factor in the rat","volume":"177","author":"Castell","year":"1988","journal-title":"Eur J Biochem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0410217","article-title":"Gp130 at the nexus of inflammation, autoimmunity, and cancer","volume":"88","author":"Silver","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90411-7","article-title":"Molecular cloning and expression of an IL-6 signal transducer, gp130","volume":"63","author":"Hibi","year":"1990","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-13-05429.1999","article-title":"Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation","volume":"19","author":"Nakashima","year":"1999","journal-title":"J Neurosci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001135","article-title":"Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation","volume":"186","author":"Haroon","year":"2011","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3898","article-title":"Astrocyte barriers to neurotoxic inflammation","volume":"16","author":"Sofroniew","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.4.1120.bloodjournal8241120","article-title":"Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130","volume":"82","author":"Narazaki","year":"1993","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2830-13.2014","article-title":"Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain","volume":"34","author":"Campbell","year":"2014","journal-title":"J Neurosci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1742-2094-8-54","article-title":"Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior","volume":"8","author":"Burton","year":"2011","journal-title":"J Neuroinflamm"},{"key":"B36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1017\/S0033291719000370","article-title":"Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls","volume":"50","author":"Olesen","year":"2019","journal-title":"Psychol Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am J Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2013.10.029","article-title":"Indications of a dose-response relationship between cannabis use and age at onset in bipolar disorder","volume":"215","author":"Lagerberg","year":"2014","journal-title":"Psychiatry Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.10.023","article-title":"Cannabis use disorder is associated with greater illness severity in tobacco smoking patients with bipolar disorder","volume":"190","author":"Lagerberg","year":"2016","journal-title":"J Affect Disord"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2017.04.006","article-title":"THC and CBD in blood samples and seizures in Norway: Does CBD affect THC-induced impairment in apprehended subjects","volume":"276","author":"Havig","year":"2017","journal-title":"Foren Sci Int"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.01.011","article-title":"Human Laboratory Studies on Cannabinoids and Psychosis","volume":"79","author":"Sherif","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2014.01.018","article-title":"Immune system: a possible nexus between cannabinoids and psychosis","volume":"40","author":"Su\u00e1rez-Pinilla","year":"2014","journal-title":"Brain Behav Immun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-018-0206-1","article-title":"GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia","volume":"21","author":"Pasman","year":"2018","journal-title":"Nat Neurosci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1101\/806927","article-title":"Cannabis use is associated with increased levels of soluble gp130 in schizophrenia but not in bipolar disorder","author":"Szabo","year":"2019","journal-title":"BioRxiv.org"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00642\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:53:06Z","timestamp":1593651186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00642\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":46,"alternative-id":["10.3389\/fpsyt.2020.00642"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00642","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/806927","asserted-by":"object"}]},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"article-number":"642"}}